SCHEMBL24064809

SCHEMBL24064809

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc4n5-c4cccc(-c5cccc([Si](c6ccccc6)(c6ccccc6)c6ccccc6)c5)c4)ccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
ATM Q13315 2/20 0.49
KDM4E B2RXH2 1/20 0.49
PTGER4 P35408 1/20 0.36
KMT2A Q03164 3/20 0.36
IL1R1 P14778 1/20 0.36
TSPO P30536 1/20 0.36
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HTT P42858 2/20 0.35
MAPT P10636 1/20 0.35
NPY5R Q15761 1/20 0.34
HDAC4 P56524 1/20 0.33
GAA P10253 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
PDE10A Q9Y233 1/20 0.32
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18779566 1.00 L3MBTL1 (0.49) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18805013 0.99 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18805007 0.97 L3MBTL1 (0.46) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18805015 0.97 L3MBTL1 (0.46) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18805008 0.97 ATM (0.45) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL18779599 0.97 ATM (0.45) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL26762049 0.96 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL26762046 0.96 L3MBTL1 (0.47) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL24064802 0.96 L3MBTL1 (0.46) L3MBTL1ATMKDM4EPTGER4KMT2A
SCHEMBL17481833 0.96 L3MBTL1 (0.50) L3MBTL1ATMKDM4EPTGER4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210408400-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-30 US disclosed
US-20210376262-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376262-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE AR, ARL1, CRY1 L3MBTL1 2443/4885ATM 1616/4885KDM4E 2511/4885
US-20210408400-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SUN2, LAGE3, PPOX L3MBTL1 871/4885ATM 4241/4885KDM4E 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.